| Healthy control | T2DM | P-value | |||
---|---|---|---|---|---|---|
CC | C/- + −/− | CC | C/- + −/− | CC vs. (C/- + −/−) in healthy control | CC vs. (C/- + −/−) in T2DM patients | |
N (male/femal) | 40/33 | 0/3 | 131/87 | 18/13 | 0.203 | 0.949 |
AGE (yrs) | 52.67 ± 4.93 | 56.54 ± 7.68 | 56.26 ± 11.24 | 56.81 ± 13.14 | 0.392 | 0.830 |
SBP (mmHg) | 110.00 ± 10.00 | 117.81 ± 13.15 | 137.93 ± 20.45 | 136.06 ± 24.20 | 0.314 | 0.641 |
DBP (mmHg) | 74.00 ± 4.00 | 76.00 ± 8.07 | 83.64 ± 11.40 | 81.97 ± 11.44 | 0.672 | 0.444 |
DM duration (yrs) |  |  | 6.55 ± 5.87 | 6.41 ± 5.61 |  | 0.895 |
HbA1c (%) |  |  | 9.56 ± 2.50 | 9.58 ± 2.37 |  | 0.960 |
Cr (umol/L) | 50.50 ± 9.03 | 65.01 ± 14.63 | 75.13 ± 32.65 | 74.30 ± 24.27 | 0.094 | 0.891 |
CYS-C (mg/L) | 0.86 ± 0.10 | 0.98 ± 0.22 | 1.18 ± 0.51 | 1.15 ± .38 | 0.362 | 0.798 |
SOD (U/mL) | 107.67 ± 15.50 | 106.87 ± 10.29 | 82.63 ± 25.96 | 77.42 ± 24.34 | 0.898 | 0.292 |
FPG (mmol/L) | 5.19 ± 0.33 | 5.37 ± 0.37 | 9.43 ± 3.35 | 9.59 ± 3.22 | 0.409 | 0.807 |
TC (mmol/L) | 4.20 ± 0.16 | 4.28 ± 0.52 | 4.52 ± 1.25 | 4.05 ± .93 | 0.779 | 0.046 |
TG (mmol/L) | 0.64 ± 0.11 | 1.20 ± 0.41 | 2.22 ± 1.95 | 1.98 ± 1.35 | 0.022 | 0.503 |
HDL-C (mmol/L) | 1.49 ± 0.11 | 1.42 ± 0.19 | 1.22 ± 0.31 | 1.19 ± 0.37 | 0.560 | 0.706 |
LDL-C (mmol/L) | 2.42 ± 0.07 | 2.31 ± 0.41 | 2.55 ± 0.80 | 2.32 ± 0.74 | 0.125 | 0.119 |
ApoA-I (g/L) | 1.63 ± 0.11 | 1.68 ± 0.26 | 1.30 ± 0.34 | 1.22 ± 0.32 | 0.748 | 0.210 |
ApoB (g/L) | 0.71 ± 0.09 | 0.75 ± 0.18 | 0.91 ± 0.34 | 0.83 ± 0.29 | 0.706 | 0.228 |
LP (a) (mg/L) | 210.37 ± 54.13 | 129.60 ± 115.45 | 157.20 ± 199.35 | 156.10 ± 119.13 | 0.234 | 0.976 |
apoM (ng/uL) | 23.63 ± 8.80 | 24.93 ± 11.78 | 20.44 ± 10.21 | 18.20 ± 8.53 | 0.851 | 0.245 |